Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Raymund Razonable and Molly Destro Borgen.
Raymund Razonable
Connection Strength
1.469
Molly Destro Borgen
  1. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
    View in: PubMed
    Score: 0.933
  2. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
    View in: PubMed
    Score: 0.244
  3. Infection prevention and control considerations for safe outpatient monoclonal antibody infusions in patients with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 Mar 12; 1-2.
    View in: PubMed
    Score: 0.233
  4. A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities. J Am Geriatr Soc. 2021 04; 69(4):868-873.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.